Henry Ford Cancer Institute-Henry Ford Hospital — Detroit, Michigan

Henry Ford Cancer Institute-Henry Ford Hospital is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Institute-Henry Ford Hospital has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Institute-Henry Ford Hospital?

Henry Ford Cancer Institute-Henry Ford Hospital has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Institute-Henry Ford Hospital conducted?

Henry Ford Cancer Institute-Henry Ford Hospital has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Is Henry Ford Cancer Institute-Henry Ford Hospital accredited by Crixeo Health?

Henry Ford Cancer Institute-Henry Ford Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer Institute-Henry Ford Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.